检索历史清除

首页> Journal of Clinical Oncology> Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody

Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody

导出原文传递

翻译打印收藏纠错

作者： Maher, V. Ellen ^[1] ; Fernandes, Laura L. ; Weinstock, Chana ; Tang, Shenghui ; Agarwal, Sundeep ; Brave, Michael ; Ning, Yang-min ; Singh, Harpreet ; Suzman, Daniel ; Xu, James ; Goldberg, Kirsten B. ; Sridhara, Rajeshwari ; Ibrahim, Amna ; Theoret, Marc ; Beaver, Julia A. ; Pazdur, Richard

作者单位： US FDA, Silver Spring, MD 20993 USA ^[1]

发布时间 2020-03-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交